Who's here
No results found for your selection.
AAB Therapeutics develops precision therapies using engineered extracellular vesicles to deliver targeted RNA treatments for cancer and autoimmune diseases, improving efficacy while reducing side effects.
https://www.aab-therapeutics.com
AbOliGo is a company developing a revolutionary approach for rapid production of antibody-oligonucleotide conjugates (AOCs), addressing a critical bottleneck in multiplexed protein analysis, proteomics and spatial biology.
https://aboligo.com
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena's complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals.
https://abzena.com
Artios Pharma is a biotech specialising in DNA damage response (DDR) as a therapeutic area for novel cancer treatments.
https://www.artios.com
Athernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established. The company’s primary focus is high-risk clonal haematopoiesis (CH), a widespread precursor which can lead to acute myeloid leukaemia and other haematological cancers. High-risk CH affects multiple groups, including patients with rare blood disorders, cancer survivors, and the ageing population. Athernal Bio’s initial programme will target an orphan indication in patients with rare blood disorders, associated with aggressive and highly accelerated CH.
https://www.athernalbio.com
Axol Bioscience is a leading customer service provider for iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery.
https://axolbio.com
The Babraham Institute is a world-class research institution, situated at the heart of the Babraham Research Campus.
https://www.babraham.ac.uk
Biosceptre International is a public, unlisted biotechnology company based in Sydney, Australia and Cambridge, UK. Biosceptre is developing and commercializing antibody technologies to address a wide range of applications in the diagnosis and treatment of cancer.
https://www.biosceptre.com
bit.bio is dedicated to producing and democratising access to stem cell derived functional human cells for research, drug discovery, and cell therapy. This will improve research and drug discovery, lower the cost and extend the application of cell therapies.
https://www.bit.bio
Cambivac Ltd researches, develops and out-licenses innovative vaccine technologies. It benefits from a close relationship with the University of Cambridge which facilitates its aims of bringing together world class expertise in the fields of traditional virology, modern genomics and molecular vaccine approaches.
Cambridge Nucleomics develops rapid RNA-based diagnostics using a single-molecule detection platform, enabling fast, accurate measurement of biomarkers to support time-critical clinical decisions.
https://www.cambridge-nucleomics.com/
Cambridge Protein Arrays Ltd. is a biotech SME founded in 2010 by Dr Mike Taussig, based on strong academic roots in the fields of protein arrays and protein affinity reagents. Cambridge Protein Arrays Ltd offers products and services in the area of protein microarrays.
https://cambridgeproteinarrays.com
Cambridge Protein Works produce pure proteins for research professionals in industry and academia, saving our customers the considerable effort, time and cost of protein expression and purification.
https://cambridgeproteinworks.com
Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), formerly CRT Discovery Laboratories, is the in-house Cancer Research UK drug discovery unit with a principal focus on establishing and prosecuting biologically-themed multi-project alliances with industry.
https://www.cancerresearchhorizons.com/
CellCodex is a Cambridge-based, lab-in-the-loop CRO that produces AI-grade perturbation datasets across human cell models. It combines scalable CRISPR and multi-omic profiling with rigorous QC to deliver causal, decision-ready data packages for pharma and AI-biotech teams. Its platform accelerates target discovery, mechanism-of-action mapping, and AI-model training.
https://cellcodex.bio
Cell Guidance Systems offers services and products for life science research. We focus on the field of regenerative medicine. In addition to reagents for stem cell research (growth factors, small molecules, cell culture media) we also offer a growing list of products for exosome research.
https://www.cellgs.com
Central Pharma offer a range of pharmaceutical services. From filling and packing, specialist storage, serialisation to regulatory support, they can support your full supply chain.
https://www.centralpharma.com
Delivering transformational medicines through 3D deep learning and cutting-edge drug discovery technologies.
https://charmtx.com
Cyclana Bio is developing tissue-level drug discovery approaches to advance new treatments in women’s health, starting with endometriosis, using human tissue data to identify novel therapeutic targets.
https://www.cyclanabio.com/
Empyrean Therapeutics is focused on developing next generation off-the-shelf cell therapies to enable global and affordable cures for cancer and rare disease.
https://empyrean.bio
Ensocell is a new venture capital-backed Life Science company at the intersection of single cell genomics, spatial genomics, AI, and drug discovery.
Engivent develops modular microfluidics and automation platforms that enable programmable, high-throughput biological experiments, generating rich datasets to accelerate discovery in protein science and synthetic biology.
https://engivent.com/
Epitopea is developing accessible off-the-shelf cancer RNA immunotherapies which will deliver more durable benefits to patients.
https://www.epitopea.com
Redefining the status quo of protein expression.
https://www.expressionedits.com
Forth TX is a company developing precision for fibrotic disease.
https://forthtx.com
Harness Therapeutics is a biotechnology company focused on physiological protein upregulation to develop next generation therapeutics for the treatment of neurodegenerative diseases.
https://www.harnesstx.com
Insmed is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells.
https://insmed.com
LinkGevity, an AI-enabled biotech company, focuses on developing therapeutics for complex age-related diseases. Our computational Drug Discovery Platform is guided by a novel proprietary theory of ageing.
https://www.linkgevity.com
LYEONS is a neurotechnology company developing sensory-based solutions to improve brain health, targeting anxiety, stress and sleep disorders through non-invasive, research-driven interventions.
https://lyeons.com/
MitoRx Therapeutics develops mitochondrial-targeted small molecule therapies to treat obesity and metabolic disease, enabling fat loss while preserving muscle and restoring healthy metabolism.
https://www.mitorxtherapeutics.com/
Resolving Cancer’s Complexity: Mosaic is reshaping the interface of computational and experimental biology to power new combination therapies for patients.
https://mosaic-tx.com
Myonerv develops wearable neurotechnology that helps stroke patients regain movement, using intention-driven stimulation to support continuous rehabilitation both in clinic and at home.
https://www.myonerv.co/
Neela Biotech develops carbon-negative aviation fuels by converting waste into sustainable jet fuel using AI-driven microbial processes, offering a scalable alternative to fossil fuels.
https://www.neelabiotech.com/
NeoGenomics provides advanced cancer diagnostics and genomic testing services, helping clinicians and researchers generate insights to support diagnosis, treatment selection and drug development.
https://www.neogenomics.com/
New Path Molecular specialises in the chemical synthesis of complex functional molecules using the cutting edge techniques, methods and instrumentation developed in the laboratories of Prof Steve Ley at the University of Cambridge. Our processes and molecules are being used to validate biological processes and produce products globally.
https://www.newpathmolecular.com
The Nikon BioImaging Lab (NBIL) is a Contract Research Organization (CRO) that provides microscope-based imaging and analysis services to the biotech, pharma, and larger research communities, offering contract research services from the company that knows imaging.
https://www.microscope.healthcare.nikon.com/bioimaging-centers/nikon-bioimaging-labs/europe
Ojas Immune is developing synthetic biology platforms that reprogram macrophages, aiming to harness the innate immune system to treat a broad range of diseases.
https://ojasimmune.com/
Cambridge-London Life Science membership organisation. We support Europe’s largest Life Science cluster encompassing the London-Cambridge-East of England region via knowledge transfer, connectivity, inward investment and growth.
https://onenucleus.com
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being.
We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. We believe that health and well-being create the foundation for a good life and society.
We are continuously developing new drugs and treatment methods. The core therapy areas of our pharmaceutical R&D are oncology and pain.
We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies.
https://www.orionpharma.co.uk
PhoreMost has developed a next-generation phenotypic screening platform called SITESEEKER® which can discern the best new targets for future therapies and, crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancers and other disease of unmet need.
https://www.phoremost.com
Pixl.bio combines human cell models, automated imaging and AI-driven phenomics to generate predictive insights from cellular data, helping improve drug discovery and safety assessment.
https://www.pixl.bio/
PlaqueTec is pioneering the development of biomarker-based strategies to transform the prevention, diagnosis, and treatment of Coronary Artery Disease, the leading cause of death worldwide.
https://www.plaquetec.com
Promatix is a UK-based startup developing new classes of cancer therapies using bispecific antibodies.
https://pro-matix.com
By tracking an individual's proteotype, Proteotype Diagnostics provide a minimally invasive approach to monitor on-treatment response, such as acquired resistance to treatment, with the potential to impact dosage and efficacy.
https://proteotype.com
RxCelerate is an out-sourced drug development company, delivering complete preclinical drug development programmes and project management for virtual and semi-virtual companies.
https://www.rxcelerate.com
Sanofi is a global biopharmaceutical company developing and delivering innovative medicines and vaccines, with a strong focus on R&D and AI-driven science to improve patient outcomes worldwide.
https://www.sanofi.com/en
SENISCA is an award-winning biotech from the University of Exeter, focused on modulating RNA biology to treat age-related disease.
SENISCA targets the process of cellular ageing (senescence) via the development of RNA senotherapeutics which specifically target the causative molecular mechanisms that drive senescence.
Age-related disease is caused by the failure in basic cell health mechanisms, collectively known as the hallmarks of ageing. 15+ years of world-leading research by SENISCA's founders led to the identification of a novel hallmark of ageing, dysregulated RNA splicing, a fundamental contributor to cellular senescence and ageing. We are leveraging this proprietary knowledge to develop senotherapeutics that specifically reverse senescence for the treatment of age-related disease.
https://www.senisca.com
SMIN Therapeutics develops oral small-molecule therapies for autoimmune diseases, targeting underlying immune pathways to deliver effective, scalable treatments that are easier for patients to access and use.
https://www.smintx.com/
Sphere Bio develops single-cell analysis and isolation technologies using microfluidics, enabling researchers to rapidly identify, analyse and select high-value cells to accelerate biologics discovery and development.
https://spherebio.com
Developing RNA gene therapies for aggressive cancers.
https://spliceor.com
A pioneering platform for targeted drug development. We account for individual variations in patients’ genetics, physiology and health, enabling the most precise, carefully targeted drug development. Delivering a safer, more cost-effective drug discovery for the human race.
https://stemnovate.co.uk
Tagomics develops multiomic profiling technologies that combine genomic, epigenetic and fragmentomic data to identify disease biomarkers, enabling earlier and more accurate diagnosis.
https://tagomics.com
Takeda's mission is to strive towards Better Health and a Brighter Future for people worldwide through leading innovation in medicine.
https://www.takeda.com/en-gb/
TRIMTECH Therapeutics develops targeted protein degradation therapies that selectively remove toxic protein aggregates, aiming to treat neurodegenerative and inflammatory diseases such as Alzheimer’s.
https://trimtechtherapeutics.com/
Talisman Therapeutics Ltd is a human stem cell drug discovery company. We are committed to revolutionising the discovery of treatments for Alzheimer's disease (AD). Our novel human stem cell models of AD provide a transformative platform for rapid and relevant compound identification, which significantly accelerate drug discovery.
https://talisman-therapeutics.com
TRX’s technology enables targeted oral drug delivery to specific organs, cells and tissues in cancer, CNS and respiratory diseases and diseases of the immune system using a clinically and developmentally proven approach.
https://www.trxbiosciences.com
We take our inspiration, and our name, from the principle of exaptation – the concept that a trait which evolved for one purpose can be harnessed to serve an entirely different function.
Using the power of genome editing and synthetic biology, we’ve converted nature’s ultimate first-responder cell into a modular chassis, ready to be programmed to treat disease.
https://www.xaptherapeutics.com
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals.
https://www.zoetis.com
Job vacancies
Babraham Research Campus offers an exciting opportunity to work at one of the UK’s leading hubs for early‑stage bioscience. Whether you’re a scientist, innovator, or professional looking to make an impact, our vacancies invite you to join a community that’s driving the future of life sciences.